1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Marcus Altfeld, M.D., Ph.D.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART) HIV gp120/NefTat/AS02A Vaccine - HIV Infections | Phase 1 | Completed | Marcus Altfeld, M.D., Ph.D. | 20 | 2005-06-01 | 2010-02-15 |
HIV Infections (1)
HIV Envelope Protein gp120 (1)
United States (1)
Marcus Altfeld, MD/PhD (1) · Mathias Lichterfeld, MD/PhD (1)